Zepp Health Corporation (ZEPP) P/E Ratio History
Historical price-to-earnings valuation from 2020 to 2022
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 2, 2026, Zepp Health Corporation (ZEPP) trades at a price-to-earnings ratio of -1.0x, with a stock price of $19.28 and trailing twelve-month earnings per share of $-121.14.
The current P/E is 276% below its 5-year average of 0.6x. Over the past five years, ZEPP's P/E has ranged from a low of 0.1x to a high of 1.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 25.2x, ZEPP trades at a 104% discount to its sector peers. The sector includes 345 companies with P/E ratios ranging from 0.0x to 199.1x.
Relative to the broader market, ZEPP trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZEPP DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $5.80 | $12.72 | 0.5x | -17% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $5.48 | $52.40 | 0.1x | -81% |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $20.20 | $60.08 | 0.3x | -39% |
| FY2020 Q4 | $47.40 | $49.48 | 1.0x | +74% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $51.40 | $57.08 | 0.9x | +63% |
Average P/E for displayed period: 0.6x
See ZEPP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZEPP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ZEPP vs NVDA
See how ZEPP stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is ZEPP stock overvalued or undervalued?
ZEPP trades at -1.0x P/E, below its 5-year average of 0.6x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ZEPP's valuation compare to peers?
Zepp Health Corporation P/E of -1.0x compares to sector median of 25.2x. The discount suggests lower growth expectations or higher risk.
What is ZEPP's PEG ratio?
ZEPP PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2020-2022.